Abiopharma

🔍 Fernandez Jose A (Director)

Company: StepStone Group Inc. (STEP)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Acquired 200,000 shares of Class A Common Stock (Direct)
  Date: 2026-03-31 | Code: C | equity_swap_involved: 0 | shares_owned_after: 200,000.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Sold 200,000 shares of Class B Common Stock at $0.001 per share (Direct)
  Date: 2026-03-31 | Code: D | equity_swap_involved: 0 | shares_owned_after: 3,016,601.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-03-31 | Code: H | shares_owned_after: 18,828.00
• Holds 0 shares of Class B Common Stock (Direct)
  Date: 2026-03-31 | Code: H | nature_of_ownership: By Santaluz Capital Partners, LLC | shares_owned_after: 1,605,500.00
• Sold 200,000 shares of Class B Units (Derivative)
  Date: 2026-03-31 | Code: C | equity_swap_involved: 0 | shares_owned_after: 3,016,601.00 | transaction_form_type: 4 | Footnotes: F2, F1, F1, F2, F2
• Holds 1,605,500 shares of Class B Units (Derivative)
  Date: 2026-03-31 | Code: H | shares_owned_after: 1,605,500.00 | Footnotes: F2, F2, F2

Footnotes:

• F1: On March 31, 2026, the Reporting Person exchanged 200,000 Class B Units of StepStone Group LP (the "Partnership") for 200,000 shares of Class A Common Stock. In connection with the exchange, 200,000 shares of Class B Common Stock were automatically redeemed and cancelled.
• F2: The Class B Units are exchangeable, on a one-for-one basis, for shares of Class A Common Stock of the Issuer. Upon exchange of a Class B Unit, the corresponding share of Class B Common Stock of the Issuer will be automatically redeemed and cancelled.